降尿酸创新药物研发/Developing innovative drugs for reducing uric acid - 北京协同创新研究院
新闻动态 | 党群建设 | 联系我们
首页 / / 降尿酸创新药物研发/Developing innovative drugs for reducing uric acid
降尿酸创新药物研发/Developing innovative drugs for reducing uric acid

       高尿酸血症能导致痛风,也是代谢综合症 、慢性肾病、心血管疾病和脑卒中的独立危险因素。高尿酸血症患者即使无明显症状也应控制尿酸含量,但目前尚无治疗药物。本药物(DHNB)源自中药提取物,是新型XOR酶抑制剂,安全性极佳。

      可开发用于无明显症状高尿酸血症治疗。

       Hyperuricemia can cause gout and is an independent risk factor for metabolic syndrome, chronic kidney disease, cardiovascular disease, and stroke. No drug can be used to treat asymptomatic hyperuricemia. This drug (DHNB) is derived from a traditional Chinese medicine extract and is a novel XOR inhibitor with excellent drug safety.

         DHNB has potential to be used to treat asymptomatic hyperuricemia.